Prime Medicine (PRME) Accumulated Expenses (2021 - 2026)

Prime Medicine (PRME) has 6 years of Accumulated Expenses data on file, last reported at $8.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 11.89% year-over-year to $8.1 million; the trailing twelve-month figure through Mar 2026 stood at $8.1 million (down 11.89% YoY), and the FY2025 full-year result was $12.6 million, down 20.77% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $8.1 million, down from $12.6 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $18.7 million in Q3 2024 and bottomed at $300000.0 in Q2 2023.
• The 5-year median for Accumulated Expenses is $10.9 million (2024), against an average of $10.6 million.
• The widest annual swing landed in 2022, when Accumulated Expenses sank 71.26%; it then jumped 3531.67% in 2024.
• A 5-year view of Accumulated Expenses shows it stood at $10.7 million in 2022, then soared by 32.02% to $14.1 million in 2023, then gained by 12.71% to $15.9 million in 2024, then fell by 20.77% to $12.6 million in 2025, then slumped by 35.73% to $8.1 million in 2026.
• The last three Accumulated Expenses figures came in at $8.1 million (Q1 2026), $12.6 million (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.

Peer Comparison